Category
Tofacitinib
CAS Number
540737-29-9
Molecular Formula
C22H28N6O8
Molecular Weight
504.49 g/mol
Synonym

(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile; 2-Hydroxy-1,2,3-propanetricarboxylate;

Keywords
Enzyme inhibitors
Heterocycles
Nucleotides
bases and related reagents
Pharmaceutical Standards
Intermediates
Fine Chemicals
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Tofacitinib citrate is an oral Janus kinase (JAK) inhibitor used to manage autoimmune and inflammatory disorders by modulating immune signaling pathways. It is primarily applied in the treatment of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and some immune-mediated skin conditions.